Investing in science and technology.
A private investment firm built around a physician-led biotech edge and proprietary trading technology. KTR Capital offers accredited investors institutional access across biotech, quantitative trading, and private equity — in a single fund.
A diversified platform, one capital base.
KTR Capital is built around a physician-led biotech edge and proprietary trading technology, with a diversified platform spanning biotech, quantitative trading, and private equity. Each vertical generates independent value within a single fund.
Quantitative Trading
A proprietary automated options strategy trading SPY and QQQ by reading the structural mechanics of institutional order flow. Built and operated entirely in-house on institutional-grade market data and execution infrastructure.
Research & Development
Longer-horizon applied research and the intellectual property that supports the broader platform, including advanced signal-processing methods that strengthen the firm's trading and analytics capabilities.
Biotechnology
A private-equity position in Strandwise, a biotech company developing implantable biosensor technology for continuous, post-surgical cancer monitoring — built on a physician-led understanding of the clinical need.
About KTR Capital
Private Investment Firm
Austin, Texas
KTR Capital is a private investment firm that combines a physician-led biotech edge with proprietary trading technology. Our approach applies deep clinical and scientific expertise to public-market biotech, alongside systematic, in-house quantitative strategies — a discipline built on measurement, reproducibility, and risk management.
Through KTR Capital Fund I, accredited investors gain a single, diversified allocation across the firm's strategies: a long/short oncology biotech portfolio, the HELIOS quantitative trading system, and a private-equity position in Strandwise. The firm also operates real commercial businesses, generating revenue alongside investment returns.
Begin your investor qualification.
We work with institutional allocators, family offices, and qualified individual investors. Create an account to begin qualification and access the platform. Existing investors can sign in to their portal.
KTR Capital Fund I is offered only to accredited investors. Creating an account begins a qualification process; it is not an offer to sell or a solicitation to buy securities. Investor eligibility is verified before any investment.